CYTORI THERAPEUTICS, INC. 4
4 · CYTORI THERAPEUTICS, INC. · Filed Jun 15, 2016
Insider Transaction Report
Form 4
RICKEY DAVID
Director
Transactions
- Exercise of In-Money
Subscription Rights (Right to Buy)
2016-06-15−6,000→ 0 total(indirect: By Trust)Exercise: $2.55From: 2016-05-26Exp: 2016-06-10→ See Footnote (6,000 underlying) - Exercise of In-Money
Common Stock
2016-06-15+6,000→ 24,004 total(indirect: By Trust) - Exercise of In-Money
Subscription Rights (Righ to Buy)
2016-06-15−16,000→ 0 total(indirect: By Trust)Exercise: $2.55From: 2016-05-26Exp: 2016-06-10→ See Footnote (16,000 underlying) - Exercise of In-Money
Common Stock
2016-06-15+16,000→ 71,226 total(indirect: By Trust) - Exercise of In-Money
Warrants (Right to Buy)
2016-06-15+3,000→ 3,000 total(indirect: By Trust)Exercise: $3.06From: 2016-06-15Exp: 2018-12-14→ Common Stock (3,000 underlying) - Exercise of In-Money
Warrants (Right to Buy)
2016-06-15+8,000→ 8,000 total(indirect: By Trust)Exercise: $3.06From: 2016-06-15Exp: 2018-12-14→ Common Stock (8,000 underlying)
Footnotes (4)
- [F1]These securities are owned by the Dave Rickey and Daughters Foundation Charitable Trust.
- [F2]These securities are owned by The David M Rickey Trust u/a DTD 5/8/2002, David M. Rickey Trustee.
- [F3]The common stock and the warrants reported on this Form 4 were acquired pursuant to the exercise of subscription rights previously distributed by Cytori Therapeutics, Inc. (the "Company) to all holders of the Company's common stock. The subscription rights entitled each recipient thereof to purchase units ("Units"). Each Unit consists of one share of the Company's common stock and 0.5 of a warrant, with each warrant representing the right to purchase one share of the Company's common stock. The purchase price for each Unit was $2.55
- [F4]Each warrant entitles the holder to purchase one share of the Company's common stock at an exercise price of $3.06 from the date of issuance through December 14, 2018.